These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16163627)

  • 1. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
    Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
    Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
    Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
    Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
    JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
    Sacks SL
    J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
    Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
    J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famciclovir: review of clinical efficacy and safety.
    Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
    Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
    Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
    Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study.
    Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J;
    Sex Health; 2008 Sep; 5(3):219-25. PubMed ID: 18771636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
    Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
    J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.
    Bodsworth N; Fife K; Koltun W; Tyring S; Abudalu M; Prichard M; Hamed K
    Curr Med Res Opin; 2009 Feb; 25(2):483-7. PubMed ID: 19192993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.